Alecnib 150 mg is identified on this website as a product containing alectinib, an oral targeted anticancer medicine used for certain patients with ALK-positive non-small cell lung cancer (NSCLC).
Taking alectinib correctly is important for following the prescribed treatment plan. Patients should understand the administration instructions, food requirements, missed-dose guidance, possible side effects, and precautions associated with treatment.
Alectinib should only be taken under the supervision of a qualified healthcare professional. Patients must follow their individual prescription and the product-specific instructions supplied with their medicine.
Important: This page explains general administration information for alectinib, primarily using the reference product Alecensa. The actual formulation, dosage, and instructions for Alecnib should be confirmed through its original packaging and applicable prescribing documentation.
1. Before Taking Alecnib
Before starting treatment, patients should make sure that the medicine has been prescribed by an appropriate healthcare professional.
Alectinib is intended for selected patients with ALK-positive NSCLC. The relevant ALK alteration should be confirmed through appropriate molecular testing.
Before taking the medicine, patients should:
- Confirm the prescribed product and active ingredient.
- Check the stated strength.
- Confirm the dosage form.
- Review the prescription instructions.
- Check the expiry date.
- Inspect the packaging for damage.
- Read the applicable patient information.
- Discuss existing medical conditions with the oncologist.
- Inform the healthcare team about all other medicines and supplements.
Do not start treatment simply because a product contains alectinib. A healthcare professional must confirm that it is appropriate for the patient’s diagnosis.
2. What Is the Recommended Alectinib Dose?
For the reference product Alecensa, the recommended adult dose in the United States prescribing information is 600 mg twice daily with food.
The reference product is supplied as 150 mg capsules in the United States. Four 150 mg capsules make up one 600 mg dose.
Reference adult dosing example
Morning
600 mg
Four 150 mg capsules
Evening
600 mg
Four 150 mg capsules
This is reference-product information, not an individualized prescription or confirmed Alecnib dosage instruction.
The prescribed dose may be different if treatment-related adverse reactions occur or if the healthcare professional determines that an adjustment is necessary.
Never calculate or change your dose independently.
3. Take Alectinib With Food
The reference Alecensa capsule formulation should be taken with food.
Food is part of the administration instructions for this product. Patients should follow the instructions provided by their healthcare professional and the applicable product information.
Helpful practices include:
- Take the medicine with a meal.
- Maintain a consistent daily routine.
- Avoid deliberately taking the reference formulation on an empty stomach.
- Discuss eating difficulties with the healthcare team.
- Follow any additional product-specific instructions.
If nausea or appetite loss makes it difficult to eat, consult the treating oncologist rather than changing the dosage schedule.
4. How Often Should Alecnib Be Taken?
The standard adult regimen for reference Alecensa is twice daily.
Patients generally follow a morning and evening schedule, with the doses taken according to their prescription.
A consistent routine may help reduce missed doses.
For example, patients may organize their medicine schedule around two regular meals, provided this follows their prescription.
The exact timing should be confirmed with the prescribing healthcare professional.
5. How to Swallow the Medicine
For the reference Alecensa capsule formulation, patients should swallow the capsules whole.
General administration instructions include:
- Check the prescribed dose.
- Take the required capsules according to the prescription.
- Swallow the capsules whole.
- Take them with food.
- Follow the prescribed morning and evening schedule.
Do not open, crush, chew, or dissolve the reference Alecensa capsules.
If swallowing is difficult, speak with a pharmacist or oncologist. Do not alter the medicine’s formulation without professional instructions.
6. What to Do If You Miss a Dose
Missing a dose can happen during long-term treatment.
According to the reference Alecensa instructions, if a dose is missed, patients should take the next dose at the regularly scheduled time.
Do not take an extra dose to compensate for the missed one.
Remember:
- Do not double the next dose.
- Do not take additional capsules without medical advice.
- Return to the regular schedule.
- Tell the healthcare team if missed doses occur frequently.
Patients who are unsure how to manage a missed dose should contact their pharmacist or prescribing doctor.
7. What to Do If You Vomit After Taking Alectinib
Vomiting may occur during cancer treatment and can interfere with normal eating and drinking.
For the reference Alecensa product, if vomiting occurs after taking a dose, patients should not take an additional dose to replace it.
The next dose should be taken at the regularly scheduled time.
Contact the healthcare team if vomiting is repeated, severe, or makes it difficult to maintain adequate food and fluid intake.
Do not independently repeat a dose because you are unsure how much medicine was absorbed.
8. Follow the Prescribed Treatment Schedule
Patients should take alectinib consistently according to the treatment plan established by their oncologist.
A regular schedule can help patients remember their doses and maintain communication with their healthcare team.
Useful habits include:
- Keeping a written medication schedule.
- Using a reminder if needed.
- Recording missed doses.
- Keeping the medicine in its original packaging when appropriate.
- Checking the prescription before each refill.
- Attending scheduled medical appointments.
Patients should not change the treatment schedule because of temporary symptom improvement or personal preference.
9. What If Side Effects Occur While Taking Alecnib?
Alectinib may cause side effects ranging from mild symptoms to serious adverse reactions.
Commonly reported reactions include:
- Fatigue.
- Constipation.
- Muscle pain.
- Swelling.
- Nausea.
- Rash.
- Cough.
- Changes in liver enzyme levels.
More serious safety concerns include liver injury, lung inflammation, bradycardia, muscle injury, hemolytic anemia, and kidney impairment.
Patients should report new or worsening symptoms to their healthcare professional.
The oncologist may recommend laboratory tests, clinical examinations, treatment interruption, or dose modification depending on the reaction.
Never reduce or stop the medicine independently.
10. Medicines and Supplements to Discuss With Your Doctor
Alectinib may interact with other medicines or health products.
Before starting treatment, provide the healthcare professional with a complete list of everything you use.
This includes:
- Prescription medicines.
- Non-prescription medicines.
- Vitamins.
- Minerals.
- Herbal products.
- Dietary supplements.
- Other cancer treatments.
Alectinib is metabolized primarily through CYP3A4-related pathways. Some medicines may affect its exposure or increase the risk of adverse reactions.
Do not start a new medicine or supplement without checking with a doctor or pharmacist.
11. Important Monitoring While Taking Alectinib
Regular medical monitoring helps detect possible adverse reactions and assess whether treatment remains appropriate.
For the reference Alecensa product, monitoring includes:
| Monitoring | Purpose |
|---|---|
| Liver function tests | Detect liver enzyme abnormalities and possible liver injury |
| CPK levels | Investigate muscle injury |
| Heart rate | Identify bradycardia |
| Blood pressure | Support cardiovascular assessment |
| Triglycerides | Identify elevated blood fat levels |
| Kidney function | Assess possible renal complications |
| Respiratory symptoms | Investigate possible lung inflammation |
| Imaging examinations | Assess cancer response when appropriate |
For the reference product, liver function testing is recommended every two weeks during the first three months, then monthly and as clinically indicated. CPK testing is recommended every two weeks during the first month and when unexplained muscle symptoms occur.
The treating oncologist may recommend additional tests depending on the patient’s condition.
12. Taking Alectinib With Existing Medical Conditions
Patients should discuss their medical history before starting treatment.
Additional precautions may be necessary for people with:
Liver disease: Alectinib may cause liver injury. Liver function should be assessed before and during treatment.
Kidney impairment: Kidney function should be evaluated when clinically appropriate.
Heart conditions: Alectinib may slow the heart rate. Existing heart rhythm problems and medicines that affect heart rate should be reviewed.
Muscle disorders: Unexplained muscle pain or weakness should be evaluated.
Lung conditions: New or worsening respiratory symptoms require prompt assessment.
Pregnancy or breastfeeding: Reproductive risks and applicable precautions should be discussed before treatment.
These conditions do not automatically mean alectinib cannot be prescribed. The healthcare professional must evaluate the individual situation.
13. Pregnancy and Breastfeeding Precautions
Alectinib may cause harm to an unborn baby.
Patients who are pregnant, planning pregnancy, or could become pregnant should discuss treatment risks with their oncologist.
For the reference Alecensa product, effective contraception is recommended during treatment and for label-specified periods afterward. The United States prescribing information specifies five weeks after the final dose for females of reproductive potential and three months for males with female partners of reproductive potential.
Breastfeeding is not recommended during treatment with the reference product under its United States prescribing information.
Patients should confirm all reproductive precautions against the applicable product information and obtain individualized medical advice.
14. How to Store Alecnib
Storage instructions should be taken from the original Alecnib packaging and manufacturer documentation.
General precautions include:
- Keep the medicine in its original packaging when appropriate.
- Follow the stated storage temperature.
- Protect it from unsuitable environmental conditions.
- Keep it away from children and pets.
- Check the expiry date.
- Do not use damaged or expired medicine.
- Ask a pharmacist about appropriate disposal.
Do not assume that every alectinib product has identical storage requirements.
15. What to Do If You Take Too Much
Taking more alectinib than prescribed may increase the risk of adverse reactions.
If an overdose is suspected:
- Contact a healthcare professional or local poison information service immediately.
- Explain the medicine name and amount taken, if known.
- Provide the time the medicine was taken.
- Follow professional instructions.
- Seek emergency care if severe symptoms occur.
Do not wait for symptoms to appear before seeking advice.
Do not attempt to compensate for an overdose by independently skipping or changing future doses.
16. When Should You Contact Your Doctor?
Patients should contact their healthcare professional if they experience:
- Persistent nausea or vomiting.
- Severe constipation.
- New or unexplained muscle pain.
- Unusual fatigue or weakness.
- Swelling that is worsening.
- Yellowing of the skin or eyes.
- Dark urine.
- New or worsening cough.
- Shortness of breath.
- Dizziness or fainting.
- Reduced urine output.
- Other unexpected or concerning symptoms.
Severe breathing difficulty, fainting, serious allergic reactions, or other potentially life-threatening symptoms require immediate medical attention.
17. Tips for Maintaining a Consistent Treatment Routine
A consistent routine can help patients follow long-term cancer treatment.
Consider the following practices:
- Keep a current copy of your prescription.
- Organize doses around regular meals when appropriate.
- Use reminders if you find them helpful.
- Record missed doses.
- Keep medicine packaging available.
- Check the expiry date before use.
- Maintain a list of other medicines.
- Attend laboratory appointments.
- Report side effects promptly.
- Ask questions whenever instructions are unclear.
Caregivers may also help patients maintain their schedule and arrange medical appointments.
18. Important Things to Remember When Taking Alecnib
Before and during treatment, patients should remember:
- Alectinib is a prescription anticancer medicine.
- ALK-positive disease must be appropriately confirmed.
- The correct dose must come from the treating oncologist.
- The reference Alecensa formulation is taken with food.
- Reference capsules should be swallowed whole.
- A missed dose should not be replaced with an extra dose.
- Vomiting after a reference Alecensa dose does not call for a replacement dose.
- Side effects should be reported.
- Regular laboratory monitoring is important.
- Drug interactions should be reviewed.
- Pregnancy precautions are necessary.
- Patients should not independently change or stop treatment.
Frequently Asked Questions About Taking Alecnib
Can I take Alecnib in the morning and evening?
The reference adult Alecensa regimen is twice daily. Patients should follow the exact timing provided in their individual prescription.
Should I take alectinib before or after food?
The reference Alecensa formulation should be taken with food. Follow the instructions for the specific product prescribed.
Can I crush or open the capsules?
Reference Alecensa capsules should be swallowed whole. Do not open, crush, chew, or dissolve them.
What happens if I miss two doses?
Do not take extra doses to compensate. Contact your healthcare professional for advice about your treatment schedule.
Can I take alectinib with other medicines?
Some medicines may interact with alectinib. Inform your doctor or pharmacist about all medicines and supplements you use.
Can I stop taking alectinib if I feel better?
No. Continue treatment according to your prescription unless your oncologist advises otherwise.
Can I change the dosage if I experience side effects?
No. Dose reductions and treatment interruptions must be directed by the treating healthcare professional.
Do I need blood tests while taking alectinib?
Yes. Regular monitoring may include liver function, CPK, triglycerides, kidney function, and other assessments according to the applicable prescribing information.
Important Medical Disclaimer
This page provides general educational information about taking alectinib. It does not replace professional medical advice, an individual prescription, or the official prescribing information.
Alecnib is identified on this website as a product containing alectinib in a stated strength of 150 mg. Its manufacturer, formulation, regulatory status, and product-specific administration instructions should be independently confirmed.
The dosage and administration examples on this page refer primarily to the United States prescribing information for the reference product Alecensa. They should not automatically be applied to every alectinib product.
Always follow your oncologist’s instructions and the applicable product information. Never start, stop, or change your cancer treatment without medical advice.